White papersEmma Bulmer2018-02-20T11:42:37+00:00

White papers

Read our latest white papers for insights into the ever-changing Bio-pharmaceutical industry.

Ed Ricketts2019-11-13T16:41:06+00:00

Risk-Based Monitoring: How do we get it right?

Risk-Based Monitoring: How do we get it right?

Ed Ricketts2019-10-22T12:50:21+00:00

Open Innovation Lottery

Open Innovation Lottery

Ed Ricketts2019-07-24T15:53:17+00:00

Health Canada: Kinapse’s perspective on HC public release of clinical information

Health Canada: Kinapse’s perspective on HC public release of clinical information

Ed Ricketts2019-07-24T15:54:01+00:00

CAPA Management: Challenges and some practical solutions

CAPA Management: Challenges and some practical solutions

Ed Ricketts2018-11-21T15:40:48+00:00

Market Access in Emerging Markets: ‘One Size Doesn’t Fit All’

Market Access in Emerging Markets: ‘One Size Doesn’t Fit All’

Ed Ricketts2018-11-21T16:08:46+00:00

Leading Practices in Quality & Compliance

Leading Practices in Quality & Compliance

Ed Ricketts2018-10-17T08:34:04+00:00

Leading Strategies for Effective Patient Recruitment and Retention

Leading Strategies for Effective Patient Recruitment and Retention

Ed Ricketts2018-09-24T11:43:02+00:00

Manufacturing Site Consolidation: managing regulatory implications

Manufacturing Site Consolidation: managing regulatory implications

Rich Jinks2018-08-23T15:10:07+00:00

Medical Affairs 2025 insight image

Medical Affairs 2025: the future of Medical Affairs

Medical Affairs 2025: the future of Medical Affairs

Rich Jinks2018-06-25T15:52:57+00:00

The digitisation of biopharmaceutical R&D

The digitisation of biopharmaceutical R&D

Rich Jinks2018-07-12T12:46:47+00:00

Enhancing productivity in biopharmaceutical R&D

Enhancing productivity in biopharmaceutical R&D

Rich Jinks2018-03-19T11:36:37+00:00

Quantifying impact in Market Access

Quantifying impact in Market Access / HEOR

Quantifying impact in Market Access / HEOR

Emma Bulmer2018-03-19T11:37:16+00:00

A meaningful measure of Regulatory volume

A meaningful measure of Regulatory volume

A meaningful measure of Regulatory volume

Rich Jinks2018-03-12T10:48:30+00:00

How to build a quality culture

How to build a Quality Culture: turning Q&C into a competitive advantage

Quality & compliance, White Papers

How to build a Quality Culture: turning Q&C into a competitive advantage

Rich Jinks2018-03-12T09:29:20+00:00

Managing performance in Patient Centricity

Managing performance in Patient Centricity

Managing performance in Patient Centricity

Rich Jinks2018-09-20T16:01:37+00:00

Creating new value for BioPharma

Creating new value for Biopharma

Creating new value for Biopharma

Rich Jinks2018-03-12T11:03:57+00:00

Capitalising on Patient Insights: a five step approach

Capitalising on Patient Insights: a five step approach

Rich Jinks2019-03-13T16:00:52+00:00

Roadmap to a successful sourcing partnership with a CRO

Roadmap to a successful sourcing partnership with a CRO

Roadmap to a successful sourcing partnership with a CRO

Rich Jinks2018-03-12T09:35:16+00:00

Clinical Trial Management Information: A Guide to Implementation

Clinical Trial Management Information: A Guide to Implementation

Clinical Trial Management Information: A Guide to Implementation

Rich Jinks2018-03-12T09:35:24+00:00

How can Regulatory Affairs be more patient-centric

How can Regulatory Affairs be more patient-centric?

How can Regulatory Affairs be more patient-centric?

Rich Jinks2018-03-12T09:35:32+00:00

Aligning Portfolio Strategy to Company Values

Aligning Portfolio Strategy to Company Values

Aligning Portfolio Strategy to Company Values

Rich Jinks2018-03-12T09:35:40+00:00

A reflection on patient centricity

A reflection on patient centricity

A reflection on patient centricity

Want to learn more?

Get in touch with our expert clinical team

hello@kinapse.com